İsmail GÜLER, Mehtap POLAT, Ebru Hacer BİBEROĞLU, Ömer Kutay BİBEROĞLU

Coexistence of preeclampsia and inherited thrombophilia in Turkish pregnant women

Background/aim: To examine the relationship of inherited thrombophilia and other thrombotic risk factors with preeclampsia (PE) in a population of pregnant Turkish women. Materials and methods: This was a case cross-sectional study in which 70 women with PE and 60 normal pregnant women were studied to find out the frequency of women with risk factors including inherited thrombophilia among preeclamptic cases. Results: Hemoglobin, platelet count, uric acid, vitamin B12, folic acid, copper, homocysteine, plasminogen activator inhibitor-1, fibrinogen, protein S, protein C, activated protein C resistance values show significant differences in women with PE in comparison to women with normal pregnancy. Conclusion: There may be a link between inherited thrombophilia and PE, at least in a sample of Turkish pregnant women. We also propose that the association between thrombophilia and PE is stronger than suggested previously. Furthermore, copper is selectively elevated in women with PE as an independent marker.

PDF

___

1. Lykke JA, Bare LA, Olsen J, Lagier R, Arellano AR, Tong C, Paidas MJ, Langhoof-Roos J. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J Thromb Haemost 2012; 10: 1320-1325.
2. Reyes LM, García RG, Ruiz SL, Camacho PA, Ospina MB, Aroca G, Accini JL, López-Jaramillo P. Risk factors for preeclampsia in women from Colombia: a case-control study. PLoS One 2012; 7: e41622.
3. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45-49.
4. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 153-157.
5. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, Goulet L, Lydon J, Seguin L, Dassa C et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009; 200: 151.e1-151.e9.
6. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, DizonTownson D, Said J, Seligsohn U, Carrier M, Solomon O, Greer IA. The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010; 7: e1000292.
7. Rasmussen A, Ravn P. High frequency of congenital thrombophilia in women with pathological pregnancies? Acta Obstet Gynecol Scand 2004; 83: 808-817.
8. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JI. Thrombophilias and adverse pregnancy outcome - A confounded problem! Thromb Haemost 2008; 99: 77-85.
9. Katz O, Paz-Tal O, Lazer T, Aricha-Tamir B, Mazor M, Wiznitzer A, Sheiner E. Severe preeclampsia is associated with abnormal trace elements concentrations in maternal and fetal blood. J Matern Fetal Neonatal Med 2012; 25: 1127-1130.
10. Fenzl V, Flegar-Metrić Z, Perkov S, Andriić L, Tatzber F, Žarković N, Duić Ž. Trace elements and oxidative stress in hypertensive disorders of pregnancy. Arch Gynecol Obstet 2013; 287: 19-24.
11. Sarwar MD, Ahmed S, Ullah MS, Kabir H, Rahman GKM, Safiqul Islam HAM. Comparative study of serum zinc, copper, manganese, and iron in preeclamptic pregnant women. Biol Trace Elem Res 2013; 154: 14-20.
12. Ohkuchi A, Iwasaki R, Suzuki H, Hirashima C, Takahashi K, Usui R, Matsubara S, Minakami H, Suzuki M. Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study. Hypertens Res 2006; 29: 161-167.
13. Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH. Maternal age and adverse pregnancy outcomes: a cohort study. Ultrasound Obstet Gynecol 2013; 42: 634-643.
14. Ales KL, Druzin ML, Santini DL. Impact of advanced maternal age on the outcome of pregnancy. Surg Gynecol Obstet 1990; 171: 209-216.
15. Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, Belogolovkin V, Bruder K, Salihu HM. Super-obesity and risk for early and late preeclampsia. BJOG 2010; 117: 997- 1004.
16. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
17. Franchi F, Cetin I, Todros T, Antonazzo P, Nobile de Santis MS, Cardaropoli S, Bucciarelli P, Biguzzi E. Intrauterine growth restriction and genetic predisposition to thrombophilia. Haematologica 2004; 89: 444-449.
18. Troeger C, Holzgreve W, Ladewig A, Zhong XY, Hahn S. Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and pre-eclamptic pregnancies. Fetal Diagn Ther 2006; 21: 56-60.
19. Kocijancic DM, Plesinac S, Plecas D, Aksam S, Kocijancic A. Correlation of biochemical parameters and neonatal outcome in patients with gestational hypertension. Clin Exp Hypertens 2013; 35: 6-10.
20. Seong WJ, Chong GO, Hong DG, Lee TH, Lee YS, Cho YL, Chun SS, Park IS. Clinical significance of serum albumin level in pregnancy-related hypertension. J Obstet Gynaecol Res 2010; 36: 1165-1173.
21. Hawkins TL, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG 2012; 119: 484-492.
22. Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with preeclampsia. J Obstet Gynaecol Res 2011; 37: 45-50.
23. Dekker AG, Morris NH. Medical conditions associated with hypertensive disorders of pregnancy. In: Sibai BM, editor. Hypertensive Disorders in Women. Philadelphia, PA, USA: W.B. Saunders; 2001. pp. 85-110.
24. Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V cambridge: a new mutation (Arg306→Thr) associated with resistance to activated protein C. Blood 1998; 91: 1140- 1144.
25. Giovanni L, Antonio AP, Danilo C, Stefano G, Therese D, Elisabetta RM, Letizia B, Elio C, Domenico A. Thrombophilias and pregnancy complications: a case-control study. Int J Biomed Sci 2007; 3: 168-175.
26. Larciprete G, Gioia S, Angelucci PA, Brosio F, Barbati G, Angelucci GP, Frigo MG, Baiocco F, Romanini ME, Arduini D et al. Single inherited thrombophilias and adverse pregnancy outcomes. J Obstet Gynaecol Res 2007; 33: 423-430.
27. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196.